Buy AXS now: trend and fundamentals are supportive (bullish moving averages, expanding MACD, strong premium/book value growth), and Street price targets were mostly raised after Q4.
Near-term expectation: momentum is positive but the pattern-based read implies a modest next-day dip risk (80% chance of ~-1.22% next day) even as the 1-week/1-month bias stays up.
Key push/pull: bullish options positioning and upbeat Q4/news flow vs. heavy hedge fund/insider selling (notable negative overhang).
Quality read: Growth is being driven by underwriting/premium expansion; net income lag vs revenue suggests some offsetting cost/claims/normalization effects, but EPS resilience is a positive signal.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: Predominantly price target raises after Q4, with most firms reiterating Buy/Outperform.
Notable upgrades/raises:
Mizuho: PT $141 (Outperform) citing accelerating premium growth and loss ratio stability.
RBC: PT $130 (Outperform) calling AXS a favorite idea in P&C for 2026.
UBS: PT $129 (Buy).
KBW: PT $130 (Outperform).
Jefferies: PT $122 (Buy), with estimates above consensus.
Roth: PT $120 (Buy) after Q4 beat.
Key bearish/tempered views:
BofA: downgraded to Neutral (PT $115) arguing the re-rating may be over and capital return may be lower.
Goldman: Neutral (PT $110) warning the P&C cycle is softening and Street estimates may be too optimistic.
Wall Street pros vs cons (summary):
Pros: Strong underwriting momentum, premium growth, book value expansion, and continued capital/return narrative.
Cons: Softening cycle risk and a view by some that valuation upside may be more limited after a strong run.
People Also Watch
Wall Street analysts forecast AXS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AXS is 120.14 USD with a low forecast of 110 USD and a high forecast of 133 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
Wall Street analysts forecast AXS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AXS is 120.14 USD with a low forecast of 110 USD and a high forecast of 133 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
2 Hold
0 Sell
Moderate Buy
Current: 106.590
Low
110
Averages
120.14
High
133
Current: 106.590
Low
110
Averages
120.14
High
133
Mizuho
Outperform
maintain
$133 -> $141
AI Analysis
2026-02-02
Reason
Mizuho
Price Target
$133 -> $141
AI Analysis
2026-02-02
maintain
Outperform
Reason
Mizuho raised the firm's price target on Axis Capital to $141 from $133 and keeps an Outperform rating on the shares. The firm says the company ended 2025 with "nice momentum." Axis is seeing accelerating premium growth and underlying loss ratio stability, the analyst tells investors in a research note.
UBS
Brian Meredith
Buy
maintain
$126 -> $129
2026-02-02
Reason
UBS
Brian Meredith
Price Target
$126 -> $129
2026-02-02
maintain
Buy
Reason
UBS analyst Brian Meredith raised the firm's price target on Axis Capital to $129 from $126 and keeps a Buy rating on the shares. Insurance brokers are well positioned for 2026, with organic revenue growth averaging 4.4% and EBITDA margins improving year over year despite property rate pressures, the analyst tells investors in a research note. With growth expectations reset and valuations reflecting a softer market, there is upside to consensus EPS and potential for multiple expansion, the firm says.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for AXS
